These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37288783)

  • 1. Identification of small molecule inhibitors of RAD52 for breast cancer therapy: in silico approach.
    Kumar M; Dubey R; Kumar Shukla P; Dayal D; Kumar Chaubey K; Tsai LW; Kumar S
    J Biomol Struct Dyn; 2024 Jun; 42(9):4605-4618. PubMed ID: 37288783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection.
    Sullivan K; Cramer-Morales K; McElroy DL; Ostrov DA; Haas K; Childers W; Hromas R; Skorski T
    PLoS One; 2016; 11(1):e0147230. PubMed ID: 26784987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel direct small-molecule inhibitors targeting HIF-2α using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations.
    Yazdani B; Sirous H; Enguita FJ; Brogi S; Wing PAC; Fassihi A
    Mol Divers; 2024 Jun; 28(3):1203-1224. PubMed ID: 37120484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors.
    Huang F; Goyal N; Sullivan K; Hanamshet K; Patel M; Mazina OM; Wang CX; An WF; Spoonamore J; Metkar S; Emmitte KA; Cocklin S; Skorski T; Mazin AV
    Nucleic Acids Res; 2016 May; 44(9):4189-99. PubMed ID: 26873923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided anti-cancer drug discovery of EGFR protein based on virtual screening of drug bank, ADMET, docking, DFT and molecular dynamic simulation studies.
    Roney M; Dubey A; Hassan Nasir M; Tufail A; Tajuddin SN; Mohd Aluwi MFF; Huq AM
    J Biomol Struct Dyn; 2024 Nov; 42(18):9662-9677. PubMed ID: 37676262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of small molecular inhibitors of SIRT3 by computational and biochemical approaches a potential target of breast cancer.
    Ullah A; Rehman NU; Islam WU; Khan F; Waqas M; Halim SA; Jan A; Muhsinah AB; Khan A; Al-Harrasi A
    Sci Rep; 2024 May; 14(1):12475. PubMed ID: 38816444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Integrated in silico Approach and in vitro Study for the Discovery of Small-Molecule USP7 Inhibitors as Potential Cancer Therapies.
    Kanan D; Kanan T; Dogan B; Orhan MD; Avsar T; Durdagi S
    ChemMedChem; 2021 Feb; 16(3):555-567. PubMed ID: 33063944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers.
    Chandramouly G; McDevitt S; Sullivan K; Kent T; Luz A; Glickman JF; Andrake M; Skorski T; Pomerantz RT
    Chem Biol; 2015 Nov; 22(11):1491-1504. PubMed ID: 26548611
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Bouricha EM; Hakmi M; Akachar J; Zouaidia F; Ibrahimi A
    J Biomol Struct Dyn; 2022 Jul; 40(11):5203-5210. PubMed ID: 33402049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.
    Hromas R; Kim HS; Sidhu G; Williamson E; Jaiswal A; Totterdale TA; Nole J; Lee SH; Nickoloff JA; Kong KY
    Breast Cancer Res; 2017 Nov; 19(1):122. PubMed ID: 29145865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico analysis of potential inhibitors for breast cancer targeting 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) catalyses.
    Islam MR; Tayyeb JZ; Paul HK; Islam MN; Oduselu GO; Bayıl I; Abdellattif MH; Al-Ahmary KM; Al-Mhyawi SR; Zaki MEA
    J Cell Mol Med; 2024 Aug; 28(15):e18584. PubMed ID: 39135338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential inhibitors of HER2 targeting breast cancer-a structure-based drug design approach.
    Singh G; Al-Fahad D; Al-Zrkani MK; Chaudhuri TK; Soni H; Tandon S; Narasimhaji CV; Azam F; Patil R
    J Biomol Struct Dyn; 2024 Sep; 42(15):8184-8201. PubMed ID: 37565730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling novel congeners from acetyllysine mimicking ligand targeting a lysine acetyltransferase PCAF bromodomain.
    Suryanarayanan V; Singh SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4303-4319. PubMed ID: 29228881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction.
    Al-Mugotir M; Lovelace JJ; George J; Bessho M; Pal D; Struble L; Kolar C; Rana S; Natarajan A; Bessho T; Borgstahl GEO
    PLoS One; 2021; 16(3):e0248941. PubMed ID: 33784323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations.
    Rezvani S; Ebadi A; Razzaghi-Asl N
    J Biomol Struct Dyn; 2022; 40(21):10665-10676. PubMed ID: 34286666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
    Agarwal S; Kashaw SK
    J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
    Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
    J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer.
    Khan FI; Lai D; Anwer R; Azim I; Khan MKA
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):172-186. PubMed ID: 31752564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.